Table 2.
Multivariate analysis predicting 28-day mortality and serious medical complications in patients with febrile neutropenia from the training set.
| qSOFA + MPV |
qSOFA + DNI |
qSOFA + RDW |
||||
|---|---|---|---|---|---|---|
| OR (95 % CI) |
p Value | OR (95 % CI) |
p Value | OR (95 % CI) |
p Value | |
| 28-day mortality | ||||||
| qSOFA | 3.290 (1.922–5.632) |
<.001 | 3.848 (2.202–6.724) |
<.001 | 3.543 (2.096–5.990) |
<.001 |
| MPV | 1.517 (1.194–1.929) |
<.001 | ||||
| DNI | 1.001 (0.987–1.016) |
.88 | ||||
| RDW | 1.073 (0.908–1.269) |
.41 | ||||
| Serious medical complications | ||||||
| qSOFA | 16.187 (8.210–31.914) |
<.001 | 18.236 (8.981–37.029) |
<.001 | 17.158 (8.766–33.585) |
<.001 |
| MPV | 1.339 (1.060–1.691) |
.01 | ||||
| DNI | 0.998 (0.977–1.020) |
.86 | ||||
| RDW | 1.167 (0.995–1.369) |
.06 | ||||
qSOFA: quick Sequential Organ Failure Assessment; MPV: mean platelet volume; DNI: delta neutrophil index; RDW: red cell distribution width; OR: odds ratio; CI: confidence interval.